HP and major depressive disorder: The docking of any of the active ingredients and the five key targets resulted in the binding affinity of − 7.7 to − 5.8, which was less than − 5 kcal/mol, demonstrating that HP might have good binding ability to the key targets in MDD patients (Fig. 10C).